Patent details

EP3004171 Title: METHODS FOR INHIBITING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF PCSK9

Basic Information

Publication number:
EP3004171
PCT Application Number:
US2014041204
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147370878
PCT Publication Number:
WO2014197752
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS FOR INHIBITING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF PCSK9
French Title of Invention:
PROCÉDÉS POUR INHIBER L'ATHÉROSCLÉROSE PAR L'ADMINISTRATION D'UN INHIBITEUR DE PCSK9
German Title of Invention:
VERFAHREN ZUR HEMMUNG VON ATHEROSKLEROSE DURCH VERABREICHUNG EINES HEMMERS VON PCSK9
SPC Number:

Dates

Filing date:
06/06/2014
Grant date:
13/10/2021
EP Publication Date:
13/04/2016
PCT Publication Date:
11/12/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/10/2021
EP B1 Publication Date:
13/10/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/06/2022
Expiration date:
06/06/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/10/2021
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, United States (US)

Name:
Sanofi Biotechnology
Address:
54 rue La Boétie, 75008 Paris, France (FR)

Inventor

1

Name:
GUSAROVA, Viktoria
Address:
United States (US)

2

Name:
SCHWAHN, Uwe
Address:
Germany (DE)

3

Name:
SASIELA, William J.
Address:
United States (US)

4

Name:
PEYMAN, Anusch
Address:
Germany (DE)

5

Name:
SCHAEFER, Hans-ludwig
Address:
Germany (DE)

Priority

1

Priority Number:
201361832459 P
Priority Date:
07/06/2013
Priority Country:
United States (US)

2

Priority Number:
13305762
Priority Date:
07/06/2013
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Number:
201361892215 P
Priority Date:
17/10/2013
Priority Country:
United States (US)

4

Priority Number:
13306436
Priority Date:
18/10/2013
Priority Country:
European Patent Office (EPO) (EP)

5

Priority Number:
201461944855 P
Priority Date:
26/02/2014
Priority Country:
United States (US)

6

Priority Number:
201462002508 P
Priority Date:
23/05/2014
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/40; A61K 39/00;

Publication

European Patent Bulletin

Issue number:
202141
Publication date:
13/10/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages